Just a few facts I've found:

- USADA misspelled the name of the substance. It's apparently "vilanterol trifenatate."
- The product of the brand name "Breo Ellipta" also contains "fluticasone furoate" that I believe would be banned in-competition because it's an inhaled glucocorticoid (as far as I can tell from Google-fu, someone correct me if I'm wrong). Not sure why that's not mentioned in the press release. Maybe because she didn't test positive for a glucocorticoid? Surprised that this fact also isn't mentioned in the linked "specific advice" for Breo Ellipta.

Veering from fact to opinion, I really don't understand the velvet glove "public warning.". She's a pro. There's specific advice on what she's taking. This isn't a contamination issue. She knew what she was taking. This seems to erode the doctrine that athletes (and particularly pros) take full responsibility for what's in their bodies. USADA seems to have considered the fact that she declared the substance while giving her test very much as an ameliorating factor. If you're aware enough of the possible doping implications to declare a substance while being tested, you're probably aware enough to spend about 1 minute researching it as soon as your Dr. prescribes it.

For a variety of reasons I've been recently disappointed by USADA for their almost apologetic approach to sanctioning athletes for what appears to be completely transparent violations of "the code."